Fermentalg SA (ALGAE)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 0.368 |
|---|---|
| 52-week range | 0.360 – 0.640 |
| Return, 1 month / 3 months | −19.3% / −23.8% |
| Return, 1 year / 3 years | −25.1% / +32.1% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -41.6% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fermentalg is a French biotechnology company based in Libourne that grows microalgae through fermentation to make ingredients for nutrition, food, animal feed and cosmetics. Its products include omega-rich oils and natural colouring agents derived from algae, which it supplies to manufacturers and formulators. The company focuses on developing its strains and production processes and on partnering with industrial customers who use these algae-based ingredients in their own products.
Fermentalg SA trades under the code ALGAE on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fermentalg SA (ALGAE) trades on the Euronext Paris in France. It last closed at EUR 0.368 on 23 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 465 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.1% and over the last three months it fell 23.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.7% | ||
| From 52-week high | -41.6% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.8% | ||
| 6-month return | -35.9% | ||
| 12-month return, skipping the last month | -7.2% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.6% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −8.0% |
|---|---|
| 1 month | −19.3% |
| 3 months | −23.8% |
| 6 months | −35.9% |
| 1 year | −25.1% |
| 3 years | +32.1% |
| 5 years | −86.8% |
Signals
| 50-day / 200-day average | 0.442 / 0.476 |
|---|---|
| Golden / death cross (60 days) | Death, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.017 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.